Table 6.
Results on symptom severity, quality of life, and body constitution in the three groups at four measurements and comparisons using GEE (n = 240)
| |
CS (n = 81) |
YS (n = 80) |
Placebo (n = 79) |
GEE (Group × Time) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
T1 |
T2 |
T3 |
T4 |
T1 |
T2 |
T3 |
T4 |
T1 |
T2 |
T3 |
T4 |
||
|
Mean |
Mean |
Mean |
Mean |
Mean |
Mean |
Mean |
Mean |
Mean |
Mean |
Mean |
Mean |
|
|
|
| (SE) | (SE) | (SE) | (SE) | (SE) | (SE) | (SE) | (SE) | (SE) | (SE) | (SE) | (SE) | Wald χ 2 | P | |
|
SS total score |
102.93 (5.33) |
61.21 (5.33) |
51.42 (5.33) |
42.29 (5.33) |
101.59 (5.37) |
66.49 (5.37) |
62.21 (5.37) |
49.76 (5.37) |
105.93 (5.40) |
87.34 (5.40) |
84.06 (5.40) |
76.83 (5.40) |
24.49 |
<0.0005 |
|
QOL total score |
59.73 (2.78) |
37.54 (2.78) |
32.56 (2.78) |
29.22 (2.78) |
58.91 (2.80) |
41.78 (2.80) |
37.86 (2.80) |
33.34 (2.80) |
60.87 (2.82) |
50.35 (2.82) |
49.32 (2.82) |
45.08 (2.82) |
19.47 |
0.003 |
|
Body constitution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gentleness |
55.31 (1.40) |
60.90 (1.40) |
61.99 (1.40) |
61.91 (1.40) |
53.47 (1.40) |
57.73 (1.42) |
59.15 (1.41) |
60.64 (1.41) |
52.42 (1.41) |
54.72 (1.42) |
56.06 (1.42) |
59.97 (1.42) |
9.02 |
0.17 |
| Qi-deficiency |
42.85 (1.80) |
35.05 (1.80) |
33.58 (1.80) |
33.57 (1.80) |
39.56 (1.80) |
37.50 (1.82) |
36.43 (1.82) |
34.82 (1.82) |
44.83 (1.81) |
42.92 (1.83) |
40.05 (1.83) |
39.27 (1.82) |
15.98 |
0.01 |
| Yang-deficiency |
38.25 (2.13) |
29.46 (2.17) |
28.57 (2.17) |
28.26 (2.15) |
39.36 (2.16) |
34.54 (2.19) |
33.96 (2.19) |
33.29 (2.16) |
42.32 (2.16) |
37.99 (2.18) |
34.99 (2.19) |
35.17 (2.17) |
6.75 |
0.35 |
| Inherited special | 41.07 (1.71) | 32.43 (1.72) | 31.33 (1.71) | 29.36 (1.71) | 39.77 (1.72) | 34.37 (1.74) | 32.13 (1.73) | 32.09 (1.73) | 39.86 (1.73) | 37.65 (1.74) | 33.91 (1.74) | 36.49 (1.74) | 16.58 | 0.01 |
SS, Symptom severity; QOL, Quality of life; CS, Cure-allergic-rhinitis Syrup group; YS, Yu-ping-feng San group; GEE, Generalised Estimating Equation test.
T1, baseline at subject recruitment; T2, immediately after intervention; T3, one month after intervention; T4, three months after intervention.